Compounds > thimerosal
Page last updated: 2024-08-17

thimerosal and Hepatitis B

thimerosal has been researched along with Hepatitis B in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.25)18.7374
1990's3 (18.75)18.2507
2000's10 (62.50)29.6817
2010's2 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geier, DA; Geier, MR; Hooker, BS; Kern, JK; King, PG; Sykes, LK1
Brandão, KG; Dórea, JG; Marques, RC1
Liu, DW; Su, Y1
Biroscak, BJ; Collins, MP; Fasano, N; Fineis, P; Fiore, AE; Stoltman, G1
Cieslak, PR; Corwith, HL; Fiore, AE; Margolis, HS; Thomas, AR1
Arndtz, N; Bach, D; Bartelsen, O; Diaconescu, IG; Rebedea, I1
Ball, R; Begier, EM; Braun, MM; Chang, S; Schech, SD; Shatin, D; Venus, P1
Burgess, S; Howard, TK; Lowell, JA; Peters, M; Shenoy, S1
van Ken, WG1
Harry, SW; Lopez, GP; Sexson, WR; Stajich, GV1
Davis, JP; Hurie, MB; Saari, TN1
Berman, S; Brayden, RM; Jones, JS; Pearson, KA; Renfrew, BL1
Kirkland, LR1
Lohiya, G1

Reviews

2 review(s) available for thimerosal and Hepatitis B

ArticleYear
[Overview on safety of hepatitis B vaccine].
    Zhongguo yi miao he mian yi, 2010, Volume: 16, Issue:1

    Topics: Hepatitis B; Hepatitis B Vaccines; Humans; Safety; Thimerosal

2010
Ocular sensitivity to thimerosal: a problem with hepatitis B vaccine?
    Southern medical journal, 1990, Volume: 83, Issue:5

    Topics: Drug Hypersensitivity; Ethylmercury Compounds; Eye Diseases; Hepatitis B; Hepatitis B Vaccines; Humans; Safety; Thimerosal; Viral Hepatitis Vaccines

1990

Trials

1 trial(s) available for thimerosal and Hepatitis B

ArticleYear
Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults.
    Vaccine, 2006, Jun-19, Volume: 24, Issue:25

    Topics: Adult; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunization Schedule; Immunoglobulin G; Male; Middle Aged; Preservatives, Pharmaceutical; Thimerosal; Vaccines, DNA; Vaccines, Synthetic

2006

Other Studies

13 other study(ies) available for thimerosal and Hepatitis B

ArticleYear
A longitudinal cohort study of the relationship between Thimerosal-containing hepatitis B vaccination and specific delays in development in the United States: Assessment of attributable risk and lifetime care costs.
    Journal of epidemiology and global health, 2016, Volume: 6, Issue:2

    Topics: Antiviral Agents; Child; Child Development; Child, Preschool; Cohort Studies; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Infant; Infant, Newborn; Longitudinal Studies; Male; Mercury; Risk Factors; Thimerosal; United States

2016
Neonate exposure to thimerosal mercury from hepatitis B vaccines.
    American journal of perinatology, 2009, Volume: 26, Issue:7

    Topics: Brazil; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Vaccines; Humans; Incidence; Infant, Newborn; Male; Preservatives, Pharmaceutical; Registries; Risk Assessment; Thimerosal; Vaccination

2009
Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.
    Pediatrics, 2003, Volume: 111, Issue:6 Pt 1

    Topics: Contraindications; Female; Health Planning Guidelines; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hospitals, Urban; Humans; Immunization Programs; Infant; Infant, Newborn; Infant, Newborn, Diseases; Mass Screening; Michigan; Pregnancy; Pregnancy Complications, Infectious; Preservatives, Pharmaceutical; Thimerosal

2003
Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:4

    Topics: Cohort Studies; Confidence Intervals; Consumer Product Safety; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunity; Immunization Schedule; Infant, Newborn; Male; Mass Screening; Oregon; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Preservatives, Pharmaceutical; Probability; Risk Assessment; Sensitivity and Specificity; Thimerosal; Vaccination

2004
Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:4

    Topics: Child, Preschool; Cohort Studies; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Immunization Programs; Immunization Schedule; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Managed Care Programs; Preservatives, Pharmaceutical; Thimerosal; United States; Vaccination

2007
Mercury poisoning associated with hepatitis-B immunoglobulin.
    Lancet (London, England), 1996, Feb-17, Volume: 347, Issue:8999

    Topics: Adult; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Liver Cirrhosis; Liver Transplantation; Male; Mercury Poisoning; Preservatives, Pharmaceutical; Thimerosal

1996
[Thiomersal in gammaglobulins for pregnant travelers may not be safe for the fetus].
    Nederlands tijdschrift voor geneeskunde, 1999, Sep-18, Volume: 143, Issue:38

    Topics: Adult; Female; Hepatitis B; Humans; Immunoglobulin gamma-Chains; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Preservatives, Pharmaceutical; Thimerosal; Travel

1999
Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.
    The Journal of pediatrics, 2000, Volume: 136, Issue:5

    Topics: Hepatitis B; Hepatitis B Vaccines; Humans; Iatrogenic Disease; Infant, Newborn; Infant, Premature; Preservatives, Pharmaceutical; Thimerosal

2000
Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices.
    MMWR. Morbidity and mortality weekly report, 2001, Feb-16, Volume: 50, Issue:6

    Topics: Hepatitis B; Hepatitis B Vaccines; Humans; Infant; Infant, Newborn; Michigan; Oklahoma; Oregon; Preservatives, Pharmaceutical; Thimerosal; Vaccination; Wisconsin

2001
From the Centers for Disease Control and Prevention. Impact of the 1999 AAP/USPHS Joint Statement on Thimerosal in Vaccines on Infant Hepatitis B Vaccination Practices. American Academy of Pediatrics/U.S. Public Health Service.
    JAMA, 2001, Mar-28, Volume: 285, Issue:12

    Topics: Hepatitis B; Hepatitis B Vaccines; Humans; Infant; Infant, Newborn; Michigan; Oklahoma; Oregon; Preservatives, Pharmaceutical; Thimerosal; Vaccination; Wisconsin

2001
Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Pediatrics, 2001, Volume: 107, Issue:4

    Topics: Academies and Institutes; Adult; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant, Newborn; Nurse Administrators; Nurseries, Hospital; Obstetrics and Gynecology Department, Hospital; Organizational Policy; Pediatrics; Preservatives, Pharmaceutical; Preventive Health Services; Thimerosal; United States; United States Public Health Service; Vaccination; Wisconsin

2001
Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.
    The Journal of pediatrics, 2001, Volume: 138, Issue:5

    Topics: Centers for Disease Control and Prevention, U.S.; Guideline Adherence; Hepatitis B; Hepatitis B Vaccines; Hospitals, Maternity; Humans; Infant, Newborn; Preservatives, Pharmaceutical; Public Health; Risk Factors; Thimerosal; United States

2001
Asthma and urticaria after hepatitis B vaccination.
    The Western journal of medicine, 1987, Volume: 147, Issue:3

    Topics: Adult; Asthma; Ethylmercury Compounds; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Thimerosal; Urticaria; Vaccination; Viral Hepatitis Vaccines

1987